纤毛黏液结节性乳头状肿瘤的组织形态学与分子谱及恶性潜能探讨
该研究收集15例纤毛黏液结节性乳头状肿瘤(CMPT)手术样本,行组织形态学、免疫组化及基因检测,发现CMPT呈双层结构,2例携带ALK重排(含1例新发现COX7C::ALK),1例BRAF V600E蛋白过表达;结合9项既往研究汇总,多数病例术后无复发转移,但罕见恶性转化,需仔细病理评估和基因检测。
要点
- CMPT虽被WHO归为良性,但形态和遗传改变提示恶性潜能未定。
- CMPT易误诊为黏液腺癌,需识别双层结构及p40/p63/CK5/6基底细胞表达。
- ALK重排病例恶性进展时可考虑ALK抑制剂靶向治疗。
核心结论
- CMPT具有双层结构及特征性免疫组化表型,可携带ALK重排或BRAF V600E过表达,多数呈惰性但罕见恶性转化,需仔细病理评估和基因检测。
研究设计与样本
- 收集15例CMPT患者手术样本,进行组织形态学、免疫组化(IHC)和基因状态分析,并汇总既往9项研究。
主要发现
- CMPT呈乳头状、腺状和微乳头状双层结构,基底细胞表达p40/p63/CK5/6,腔面和基底细胞均TTF-1免疫反应阳性。
- 二代测序显示2例携带ALK重排,其中1例首次发现COX7C::ALK重排;1例BRAF V600E蛋白过表达。
- 汇总9项既往研究,多数病例手术切除后无复发或转移,但罕见恶性转化报道。
关键数值与推荐
- 15例中2例检出ALK重排,1例为新发现的COX7C::ALK重排;1例BRAF V600E蛋白过表达。
- 汇总9项既往研究,多数病例术后无复发或转移,罕见恶性转化。
临床怎么用
- 病理诊断CMPT需识别双层结构及p40/p63/CK5/6基底细胞表达,避免误诊为黏液腺癌。
- 对CMPT病例应进行基因检测,恶性进展且伴ALK重排者可考虑ALK抑制剂靶向治疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Although the lung ciliated muconodular papillary tumor (CMPT) is defined as a benign tumor by the 5th WHO classification, recent studies have shown that its morphology and genetic alteration may indicate it has undetermined malignant potential. In clinical pathology, CMPT is easily misdiagnosed as mucinous adenocarcinoma; meanwhile, it has been reported to harbor multiple types of gene aberrant. To further study the relation between histomorphology and genetic alterations in CMPT, we collected 15 CMPT patients' surgical samples with analysis of histomorphology, immunohistochemistry (IHC), and gene status. We found CMPT features a double-layered structure with papillary, glandular, and micropapillary formations. IHC typically shows basal cells with p40/p63/CK5/6 expression and TTF-1 immunoreactivity in both luminal and basal cells. Next-generation sequencing showed that two cases harbored anaplastic lymphoma kinase (ALK) rearrangements. A new type of COX7C::ALK rearrangement is firstly revealed in one of our collected cases. One case is overexpressed BRAF (V600E) protein. We further summarized the histomorphology and molecular features of nine previous studies, finding that despite most cases follow an indolent clinical course with no recurrence or metastasis after surgical resection, rare instances of malignant transformation have been reported, underscoring the need for careful pathological evaluation and genetic testing. Our study highlights the importance of recognizing CMPT's distinct histological and molecular features and considering targeted therapies, such as ALK inhibitors, in cases with malignant progression and ALK rearrangements.
引用
- Wu J, Lin X, Li D, et al. Histomorphological and molecular spectrum of ciliated muconodular papillary tumors with implication for malignant potential: Insights from a literature review and series report. Hum Pathol. 2025. PMID: 41224024. doi:10.1016/j.humpath.2025.105981
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。